Jupiter Neurosciences, Inc. Share Price
NASDAQ: JUNS | Micro CapJupiter Neurosciences, Inc. Stock Performance
Jupiter Neurosciences, Inc. Share Price Chart
Jupiter Neurosciences, Inc. Quarterly Profit & Loss
All figures in USD
Jupiter Neurosciences, Inc. Annual Profit & Loss
All figures in USD
About Jupiter Neurosciences, Inc.
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.
Jupiter Neurosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.49 | $2.50 | +0.40% |
Sep 2026 | $3.44 | $2.49 | -48.87% |
Aug 2026 | $0.10 | $4.87 | +5,251.65% |
Jul 2026 | $0.21 | $0.09 | -57.67% |
Jun 2026 | $0.25 | $0.21 | -17.31% |
May 2026 | $0.39 | $0.26 | -32.99% |
Apr 2026 | $0.37 | $0.39 | +20.50% |
Mar 2026 | $0.49 | $0.32 | -40.15% |
Feb 2026 | $0.57 | $0.54 | +6.11% |
Jan 2026 | $1.00 | $0.51 | -53.06% |
Dec 2025 | $1.21 | $1.08 | -12.20% |
Nov 2025 | $1.38 | $1.23 | -11.51% |